$MD
Pediatrix Medical Group, Inc.

2022 Q3 Form 10-Q Financial Statement

#000095017022014473 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $489.9M $486.0M $482.2M
YoY Change -0.62% 2.76% 7.94%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $400.7M $391.9M $404.4M
YoY Change 1.29% 1.01% 4.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.956M $8.775M $8.769M
YoY Change 9.88% 8.25% 9.19%
% of Gross Profit
Operating Expenses $442.5M $435.9M $443.1M
YoY Change 1.93% 3.06% 5.34%
Operating Profit $47.39M $50.16M $39.11M
YoY Change -19.4% 0.28% 49.82%
Interest Expense $9.516M $8.409M $11.82M
YoY Change -45.92% -50.18% -33.02%
% of Operating Profit 20.08% 16.77% 30.22%
Other Income/Expense, Net -$8.528M -$7.122M -$67.45M
YoY Change -44.48% -41.27% 162.31%
Pretax Income $38.86M $43.03M -$28.35M
YoY Change -10.53% 13.57% -7386.89%
Income Tax $10.05M $12.33M -$7.401M
% Of Pretax Income 25.87% 28.66%
Net Earnings $30.73M $27.14M -$21.19M
YoY Change -0.22% -22.49% -220.1%
Net Earnings / Revenue 6.27% 5.58% -4.39%
Basic Earnings Per Share $0.37 $0.32 -$0.25
Diluted Earnings Per Share $0.37 $0.32 -$0.25
COMMON SHARES
Basic Shares Outstanding 84.35M 85.08M 85.41M
Diluted Shares Outstanding 82.78M 85.62M 85.41M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.1M $107.5M $96.76M
YoY Change -78.08% -75.51% -73.88%
Cash & Equivalents $8.668M $14.09M $7.179M
Short-Term Investments $91.40M $93.39M $89.58M
Other Short-Term Assets $9.899M $8.857M $9.080M
YoY Change -75.07% -49.06% -69.53%
Inventory
Prepaid Expenses $9.664M $14.24M $16.32M
Receivables $294.4M $307.2M $317.6M
Other Receivables $9.729M $21.53M $0.00
Total Short-Term Assets $423.7M $459.3M $439.8M
YoY Change -46.23% -38.95% -33.91%
LONG-TERM ASSETS
Property, Plant & Equipment $71.66M $72.15M $72.46M
YoY Change -1.23% 5.36% -45.68%
Goodwill $1.532B $1.532B $1.529B
YoY Change 2.36% 3.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $117.7M $124.4M $128.2M
YoY Change -9.51% 8.72% -29.13%
Total Long-Term Assets $1.908B $1.910B $1.901B
YoY Change 2.7% 5.96% 4.56%
TOTAL ASSETS
Total Short-Term Assets $423.7M $459.3M $439.8M
Total Long-Term Assets $1.908B $1.910B $1.901B
Total Assets $2.332B $2.370B $2.341B
YoY Change -11.87% -7.26% -5.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.14M $30.23M $30.32M
YoY Change -21.03% -25.64% -48.71%
Accrued Expenses $302.0M $277.8M $222.7M
YoY Change -16.27% -9.82% -16.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.92M $14.92M $2.404M
YoY Change 483.46% 537.96% 0.17%
Total Short-Term Liabilities $351.7M $329.4M $269.7M
YoY Change -11.54% -6.18% -17.51%
LONG-TERM LIABILITIES
Long-Term Debt $731.0M $793.3M $804.9M
YoY Change -27.08% -20.41% -19.26%
Other Long-Term Liabilities $42.50M $48.34M $43.87M
YoY Change 0.93% 13.65% -86.75%
Total Long-Term Liabilities $42.50M $48.34M $43.87M
YoY Change 0.93% 13.65% -96.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $351.7M $329.4M $269.7M
Total Long-Term Liabilities $42.50M $48.34M $43.87M
Total Liabilities $1.473B $1.524B $1.464B
YoY Change -18.17% -12.7% -14.74%
SHAREHOLDERS EQUITY
Retained Earnings -$118.7M -$149.5M -$176.6M
YoY Change -41.49% -36.05%
Common Stock $981.5M $997.5M $1.055B
YoY Change -6.18% -4.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $858.7M $845.4M $877.1M
YoY Change
Total Liabilities & Shareholders Equity $2.332B $2.370B $2.341B
YoY Change -11.87% -7.26% -5.75%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $30.73M $27.14M -$21.19M
YoY Change -0.22% -22.49% -220.1%
Depreciation, Depletion And Amortization $8.956M $8.775M $8.769M
YoY Change 9.88% 8.25% 9.19%
Cash From Operating Activities $83.33M $82.41M -$97.48M
YoY Change 36.38% 53.75% 18.61%
INVESTING ACTIVITIES
Capital Expenditures -$6.947M -$6.558M -$7.145M
YoY Change -34.12% -30.5% -21.48%
Acquisitions $25.67M
YoY Change 330.87%
Other Investing Activities $859.0K -$6.794M -$99.00K
YoY Change -102.8% -128.84%
Cash From Investing Activities -$6.088M -$13.35M -$26.27M
YoY Change -85.23% -194.53% 153.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$8.000K
YoY Change -100.84%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -82.66M -62.15M -256.5M
YoY Change 63000.76% -7082.7% -66.33%
NET CHANGE
Cash From Operating Activities 83.33M 82.41M -97.48M
Cash From Investing Activities -6.088M -13.35M -26.27M
Cash From Financing Activities -82.66M -62.15M -256.5M
Net Change In Cash -5.420M 6.909M -380.2M
YoY Change -127.43% -89.93% -55.49%
FREE CASH FLOW
Cash From Operating Activities $83.33M $82.41M -$97.48M
Capital Expenditures -$6.947M -$6.558M -$7.145M
Free Cash Flow $90.28M $88.97M -$90.34M
YoY Change 26.0% 41.14% 23.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33323
dei Entity File Number
EntityFileNumber
001-12111
dei Entity Registrant Name
EntityRegistrantName
Pediatrix Medical Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3667538
dei Entity Address Address Line1
EntityAddressAddressLine1
1301 Concord Terrace
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunrise
dei Document Type
DocumentType
10-Q
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.42
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2021Q4 md Accrued Contingent Consideration
AccruedContingentConsideration
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
dei Amendment Flag
AmendmentFlag
false
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
dei Entity Central Index Key
EntityCentralIndexKey
0000893949
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei City Area Code
CityAreaCode
954
dei Local Phone Number
LocalPhoneNumber
384-0175
dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
dei Trading Symbol
TradingSymbol
MD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
84353540
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14088000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
387391000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
93386000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
99715000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
307201000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
301775000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14240000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18538000
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
21529000
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14249000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8857000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18896000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
459301000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
840564000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72150000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70154000
CY2022Q2 us-gaap Goodwill
Goodwill
1532092000
CY2021Q4 us-gaap Goodwill
Goodwill
1505430000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20965000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21565000
CY2022Q2 md Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
67504000
CY2021Q4 md Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
65461000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
93218000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
88344000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124386000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131028000
CY2022Q2 us-gaap Assets
Assets
2369616000
CY2021Q4 us-gaap Assets
Assets
2722546000
CY2022Q2 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
287463000
CY2021Q4 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
394118000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
14922000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2490000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20620000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19684000
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6410000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
11074000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
329415000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
427366000
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
153500000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2022Q2 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
639754000
CY2021Q4 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
1002258000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42047000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41396000
CY2022Q2 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
268052000
CY2021Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
271093000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
43080000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
41409000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48338000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42332000
CY2022Q2 us-gaap Liabilities
Liabilities
1524186000
CY2021Q4 us-gaap Liabilities
Liabilities
1825854000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Profit Loss
ProfitLoss
5944000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84060000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84060000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86423000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86423000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
841000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
864000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
996624000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1049696000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2585000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1317000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149450000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155390000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
845430000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
896487000
CY2022Q2 us-gaap Minority Interest
MinorityInterest
0
CY2021Q4 us-gaap Minority Interest
MinorityInterest
205000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
845430000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896692000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2369616000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2722546000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
486033000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
472959000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
968262000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
919712000
CY2022Q2 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
330757000
CY2021Q2 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
317035000
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
673912000
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
636047000
CY2022Q2 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
29843000
CY2021Q2 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
24182000
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
58332000
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
46394000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61165000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
70968000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
122452000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
137484000
CY2021Q2 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
7280000
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
7280000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8775000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8106000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17544000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16137000
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
5338000
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
9932000
us-gaap Restructuring Charges
RestructuringCharges
6759000
us-gaap Restructuring Charges
RestructuringCharges
14810000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
435878000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
422943000
us-gaap Operating Expenses
OperatingExpenses
878999000
us-gaap Operating Expenses
OperatingExpenses
843592000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
50155000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
50016000
us-gaap Operating Income Loss
OperatingIncomeLoss
89263000
us-gaap Operating Income Loss
OperatingIncomeLoss
76120000
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
844000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
4176000
us-gaap Investment Income Net
InvestmentIncomeNet
1719000
us-gaap Investment Income Net
InvestmentIncomeNet
10143000
CY2022Q2 us-gaap Interest Expense
InterestExpense
8409000
CY2021Q2 us-gaap Interest Expense
InterestExpense
16879000
us-gaap Interest Expense
InterestExpense
20227000
us-gaap Interest Expense
InterestExpense
34524000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-57016000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-14532000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
443000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
577000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
948000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1072000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7122000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12126000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74576000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37841000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
43033000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37890000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14687000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38279000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12332000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7363000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4931000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2408000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
30701000
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
30527000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
9756000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35871000
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3565000
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
4478000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3812000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
16768000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
27136000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
35005000
us-gaap Profit Loss
ProfitLoss
52639000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
27136000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
35011000
us-gaap Net Income Loss
NetIncomeLoss
5948000
us-gaap Net Income Loss
NetIncomeLoss
52653000
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.36
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.36
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.36
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.42
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.20
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.19
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85078000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84912000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85190000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84660000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85619000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85933000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85914000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85653000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
896692000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-21188000
CY2022Q1 md Dissolution Of And Net Income Loss Attributable To Noncontrolling Interest
DissolutionOfAndNetIncomeLossAttributableToNoncontrollingInterest
-203000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2668000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1174000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4435000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1166000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
877076000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
27136000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1234000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1664000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5186000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
64398000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
845430000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
747717000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
17642000
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1133000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1042000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3717000
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1994000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
766983000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
35011000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
116000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1536000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5735000
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
251000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
809124000
us-gaap Net Income Loss
NetIncomeLoss
5948000
us-gaap Net Income Loss
NetIncomeLoss
52653000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3812000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
16768000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17544000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16137000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
857000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1838000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-57016000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-14532000
us-gaap Share Based Compensation
ShareBasedCompensation
8771000
us-gaap Share Based Compensation
ShareBasedCompensation
9452000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1894000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17033000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1577000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1205000
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
7280000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15950000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26005000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17044000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-40800000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-6970000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1859000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-90986000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-54453000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
12254000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
28165000
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-2768000
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-715000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-867000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10413000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8334000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-28484000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-6741000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-117000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15075000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28601000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
28167000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7207000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12983000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8355000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14039000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
10745000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
13703000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
18536000
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
24728000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1189000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39625000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1375000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2350000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39625000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3725000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
475000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
321500000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0
md Payments To Term Loan
PaymentsToTermLoan
3125000
md Payments To Term Loan
PaymentsToTermLoan
0
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1046880000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
759848000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
650000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8394000
md Repayments Of Long Term Capital Lease Obligation
RepaymentsOfLongTermCapitalLeaseObligation
1262000
md Repayments Of Long Term Capital Lease Obligation
RepaymentsOfLongTermCapitalLeaseObligation
1106000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2838000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2578000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
65564000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2245000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
284000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-189000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-318603000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-760810000
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-318603000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-760810000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-373303000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-785686000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
387391000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1123843000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14088000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
338157000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
486033000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
472959000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
968262000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
919712000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
93386000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99715000
us-gaap Debt Instrument Description
DebtInstrumentDescription
Notes are guaranteed on an unsecured senior basis by the same subsidiaries and affiliated professional contractors that guarantee the Amended Credit Agreement (as defined below). The indenture under which the 2030 Notes are issued, among other things, limits the Company's ability to (1) incur liens and (2) enter into sale and lease-back transactions, and also limits the Company's ability to merge or dispose of all or substantially all of its assets, in all cases, subject to a number of customary exceptions
CY2022Q2 md Purchase Price
PurchasePrice
1.01
CY2022Q2 md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1464374000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1393584000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1157173000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1091809000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
307201000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
301775000
CY2022Q2 md Accrued Contingent Consideration
AccruedContingentConsideration
2010000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
67643000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
41724000
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
287463000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
394118000
CY2021 md Increase Decrease In Accrued Salaries And Bonuses
IncreaseDecreaseInAccruedSalariesAndBonuses
103400
CY2021Q2 md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1
md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1
md Percentage Of Net Patient Service Revenue By Type Of Payor
PercentageOfNetPatientServiceRevenueByTypeOfPayor
1
CY2022Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
26700000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
2300000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
2200000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30234000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36645000
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
110527000
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
213974000
CY2022Q2 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
35590000
CY2021Q4 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
34994000
CY2022Q2 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
32516000
CY2021Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
37729000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
8943000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29052000
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05375
us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
payable semi-annually in arrears on February 15 and August 15, beginning on August 15, 2022
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2027-02-11
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85078000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84912000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85190000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84660000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
541000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1021000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
724000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
993000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85619000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85933000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85914000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85653000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
569000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
409000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8800000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9500000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
94000000.0
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3300000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
65600000

Files In Submission

Name View Source Status
0000950170-22-014473-index-headers.html Edgar Link pending
0000950170-22-014473-index.html Edgar Link pending
0000950170-22-014473.txt Edgar Link pending
0000950170-22-014473-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
md-20220630.htm Edgar Link pending
md-20220630.xsd Edgar Link pending
md-20220630_cal.xml Edgar Link unprocessable
md-20220630_def.xml Edgar Link unprocessable
md-20220630_htm.xml Edgar Link completed
md-20220630_lab.xml Edgar Link unprocessable
md-20220630_pre.xml Edgar Link unprocessable
md-ex10_1.htm Edgar Link pending
md-ex31_1.htm Edgar Link pending
md-ex31_2.htm Edgar Link pending
md-ex32_1.htm Edgar Link pending
md-ex3_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending